We are live on ! Find out more
SIA

Sit Investment Associates Portfolio holdings

AUM $5.28B
1-Year Est. Return 14.42%
This Fund
S&P 500
This Quarter Est. Return
-14.21%
1 Year Est. Return
+14.42%
3 Year Est. Return
+49.57%
5 Year Est. Return
+37.84%
10 Year Est. Return
+154.77%
AUM
$3.29B
AUM Growth
-$425M
Cap. Flow
+$141M
Cap. Flow %
4.28%
Top 10 Hldgs %
21.75%
Holding
545
New
30
Increased
133
Reduced
169
Closed
30

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.01%
2 Technology 15.89%
3 Healthcare 9.04%
4 Financials 6.81%
5 Industrials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MREO
501
Mereo BioPharma
MREO
$45.5M
$1K ﹤0.01%
970
GLU.RT
502
DELISTED
The Gabelli Global Utility & Income Trust Rights (expiring June 29, 2022)
GLU.RT
$1K ﹤0.01%
+293,921
New +$16K
AIT icon
503
Applied Industrial Technologies
AIT
$11.6B
-13,125
Closed -$1.35M
BRW
504
Saba Capital Income & Opportunities Fund
BRW
$319M
-91,239
Closed -$825K
BST icon
505
BlackRock Science and Technology Trust
BST
$1.65B
-112,452
Closed -$4.87M
CHGG icon
506
Chegg
CHGG
$82.4M
-128,565
Closed -$4.66M
FLC
507
Flaherty & Crumrine Total Return Fund
FLC
$168M
-7,785
Closed -$155K
GAM
508
General American Investors Company
GAM
$1.54B
-267,019
Closed -$11.3M
GDO
509
Western Asset Global Corporate Defined Opportunity Fund
GDO
$73.3M
-12,929
Closed -$192K
JPI
510
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
-220,581
Closed -$4.85M
MSM icon
511
MSC Industrial Direct
MSM
$6.69B
-1,400
Closed -$119K
NBIX icon
512
Neurocrine Biosciences
NBIX
$15.2B
-19,700
Closed -$1.85M
NIE
513
Virtus Equity & Convertible Income Fund
NIE
$698M
-198,432
Closed -$5.38M
PACB icon
514
Pacific Biosciences
PACB
$417M
-43,450
Closed -$395K
PAGS icon
515
PagSeguro Digital
PAGS
$2.65B
-3,800
Closed -$76K
PCF
516
High Income Securities Fund
PCF
$101M
-545,862
Closed -$4.32M
RIV
517
RiverNorth Opportunities Fund
RIV
$283M
-234,026
Closed -$3.74M
STT icon
518
State Street
STT
$50.9B
-109,475
Closed -$9.54M
CDMO
519
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-18,900
Closed -$385K
IHIT
520
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
-122,898
Closed -$1.07M
CERN
521
DELISTED
Cerner Corp
CERN
-1,790
Closed -$167K
ANAT
522
DELISTED
American National Group, Inc. Common Stock
ANAT
-1,005
Closed -$190K
ZNGA
523
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-120,500
Closed -$1.11M
MYJ
524
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
-58,236
Closed -$779K
MYC
525
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
-376,871
Closed -$4.91M

Similar funds

Sit Investment Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Sit Investment Associates held 545 positions worth $3.29B, down 11% from $3.71B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Sit Investment Associates deployed $141M of net new capital in Q2 2022, opening 30 new positions and adding to 133 existing holdings. Its largest new stake was Williams Companies: 333,950 shares worth $10.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Macquarie Global Infrastructure Total Return Fund, Inc., an estimated $12.4M trimmed.

  • Sit Investment Associates's largest Q2 2022 buy was Williams Companies: 333,950 shares worth $10.4M.
  • Sit Investment Associates added most to Cornerstone Strategic Value Fund in Q2 2022, an estimated $189M increase.
  • Sit Investment Associates's biggest Q2 2022 reduction was Macquarie Global Infrastructure Total Return Fund, Inc., cutting an estimated $12.4M.
  • Sit Investment Associates fully exited General American Investors Company in Q2 2022, selling an estimated $11.3M.
  • Sit Investment Associates's ten largest holdings make up 22% of its $3.29B portfolio in Q2 2022.
  • Sit Investment Associates opened 30 new positions and closed 30 in Q2 2022.
  • Sit Investment Associates's portfolio value fell 11% quarter-over-quarter to $3.29B.

Based on Sit Investment Associates's 13F filing for Q2 2022, filed 11 Aug 2022.